Recent Company News

• 04:27 AM ET Jul 31, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (138 total)

• 03:54 AM ET Jul 31, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:57 AM ET Jul 31, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:22 AM ET Jul 31, 2025
  

  StreetAccount Metrics Recap - UCB H1 Earnings (€185.40, 0.00)

• 01:12 AM ET Jul 31, 2025
  

  UCB reports H1 Core EPS €3.53 vs consensus €3.48; raises FY guidance including for revenues to reach at least €7B vs prior guidance €6.5-6.7B and FactSet €6.71B (€185.40, 0.00)

• 01:20 PM ET Jul 30, 2025
  

  StreetAccount Consensus Metrics Preview - UCB H1 Earnings (€185.40, 0.00)

• 04:58 PM ET Jul 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:58 AM ET Jul 16, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 12:41 AM ET Jul 16, 2025
  

  UCB initiated buy at Goldman Sachs (€170.70, 0.00)

• 01:10 AM ET Jul 08, 2025
  

  UCB to present 15 abstracts from its targeted neurology portfolio at the European Pediatric Neurology Society (EPNS) Congress, Munich, Germany, July 8-12, 2025 (€169.90, 0.00)